Synopsis
Synopsis
0
USDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 4-isopropyl-2,3-dimethyl-1-phenyl-3-pyrazoline-5-one
2. 4-isopropylantipyrine
3. Commotional
4. Demex
5. Hewedolor Propy
6. Isoprochin P
7. Isopropylphenazone
8. Propylphenazone
1. Isopropyl Phenazone
2. 479-92-5
3. Isopropylantipyrine
4. Isopropylphenazone
5. 4-isopropylantipyrine
6. Isopropyrine
7. Isopropylantipyrin
8. Larodon
9. Isopropylantipyrinum
10. Propifenazona
11. Propyphenazonum
12. Propyphenazon
13. Budirol
14. Cibalgina
15. Yoshipyrin
16. 1,5-dimethyl-2-phenyl-4-propan-2-ylpyrazol-3-one
17. 1-phenyl-2,3-dimethyl-4-isopropyl-3-pyrazolin-5-one
18. 1-phenyl-2,3-dimethyl-4-isopropylpyrazol-5-one
19. 4-isopropyl-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one
20. Antipyrine, 4-isopropyl-
21. Chebi:135538
22. 3h-pyrazol-3-one, 1,2-dihydro-1,5-dimethyl-4-(1-methylethyl)-2-phenyl-
23. Oed8fv75py
24. 4-isopropyl-1,5-dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one
25. 2,3-dimethyl-4-isopropyl-1-phenyl-3h-pyrazolin-5-one
26. 3-pyrazolin-5-one, 2,3-dimethyl-4-isopropyl-1-phenyl-
27. 3-pyrazolin-5-one, 4-isopropyl-2,3-dimethyl-1-phenyl-
28. 1,5-dimethyl-2-phenyl-4-(propan-2-yl)-1,2-dihydro-3h-pyrazol-3-one
29. Propyphenazone (4-isopropylantipyrine)
30. 4-isopropylantipyrine;isopropylphenazone
31. Propyphenazone (inn)
32. 4-isopropyl-1,5-dimethyl-2-phenyl-1h-pyrazol-3(2h)-one
33. Ncgc00164612-01
34. Isopropchin
35. Propifenazone
36. 4-isopropyl-1,5-dimethyl-2-phenyl-1,2-dihydro-3h-pyrazol-3-one
37. Dsstox_cid_3529
38. Dsstox_rid_77065
39. Propyphenazone [inn]
40. 4-isopropyl-2,3-dimethyl-1-phenyl-5-pyrazolone
41. Dsstox_gsid_23529
42. Propifenazone [dcit]
43. Causyth
44. Propifenazona [inn-spanish]
45. Propyphenazonum [inn-latin]
46. Cas-479-92-5
47. 4-isopropylphenazone
48. Ccris 6716
49. Propyphenazone [inn:ban:dcf]
50. Einecs 207-539-2
51. Unii-oed8fv75py
52. Brn 0204533
53. Yoshipyrin (tn)
54. 5-pyrazolone, 1-phenyl-2,3-dimethyl-4-isopropyl-
55. Propyphenazone,(s)
56. Chemdiv2_002457
57. Epitope Id:124928
58. Propyphenazone [mi]
59. Isopropylantipyrine (jp17)
60. Schembl23393
61. 5-24-01-00408 (beilstein Handbook Reference)
62. Mls004773970
63. Chembl28318
64. Propyphenazone [mart.]
65. Propyphenazone [who-dd]
66. Dtxsid6023529
67. Isopropylantipyrine [jan]
68. Pxwlvjlkjgvoke-uhfffaoysa-
69. Zinc49151
70. Hms1375p15
71. Hy-a0273
72. Tox21_112233
73. Mfcd00053368
74. Propyphenazone [ep Monograph]
75. S5309
76. Stk766727
77. 1,5-dimethyl-4-(1-methylethyl)-2-phenyl-1,2-dihydro-3h-pyrazol-3-one
78. Akos001725335
79. Tox21_112233_1
80. Ccg-266797
81. Cs-5533
82. Db13524
83. Ncgc00164612-02
84. Ac-12099
85. Bs-16890
86. Propyphenazone 1.0 Mg/ml In Acetonitrile
87. Propyphenazone 100 Microg/ml In Methanol
88. Smr001495368
89. Ft-0654525
90. I0656
91. D01380
92. D91192
93. Q425111
94. Sr-01000536454
95. 4-isopropylantipyrine, Analytical Reference Material
96. Sr-01000536454-1
97. W-106059
98. 4-isopropyl-1,5-dimethyl-2-phenyl-3-pyrazolone
99. Propyphenazone, European Pharmacopoeia (ep) Reference Standard
100. 4-isopropyl-1,5-dimethyl-2-phenyl-1,2-dihydro-3h-pyrazol-3-one #
101. Propyphenazone, Pharmaceutical Secondary Standard; Certified Reference Material
Molecular Weight | 230.31 g/mol |
---|---|
Molecular Formula | C14H18N2O |
XLogP3 | 1.7 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Exact Mass | 230.141913202 g/mol |
Monoisotopic Mass | 230.141913202 g/mol |
Topological Polar Surface Area | 23.6 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 340 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
N - Nervous system
N02 - Analgesics
N02B - Other analgesics and antipyretics
N02BB - Pyrazolones
N02BB04 - Propyphenazone
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : R1-CEP 1998-088 - Rev 00
Issue Date : 2004-12-07
Type : Chemical
Substance Number : 636
Status : Withdrawn by Holder
Certificate Number : R1-CEP 2003-059 - Rev 05
Issue Date : 2022-03-14
Type : Chemical
Substance Number : 636
Status : Valid
Certificate Number : R1-CEP 2001-041 - Rev 01
Issue Date : 2008-01-23
Type : Chemical
Substance Number : 636
Status : Withdrawn by EDQM F...
Date of Issue : 2019-09-17
Valid Till : 2022-09-16
Written Confirmation Number : WC-0188
Address of the Firm :
Registration Number : 217MF11189
Registrant's Address : 3 Himata, Toyama City, Toyama Prefecture
Initial Date of Registration : 2005-12-12
Latest Date of Registration : --
About the Company : Established in 1943 as one of the national largest manufacturing and exporting bases in the chemical synthetic pharmaceuticals field, Shandong Xinhua Pharmaceutical Company Limited...
About the Company : Stellence Pharmscience Private Limited is a company keenly involved in the business of manufacturing Active Pharmaceuticals Ingredients (API), High End Intermediates (HEIN) and Con...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
https://www.pharmacompass.com/radio-compass-blog/niche-european-molecules-is-there-a-business-opportunity-worth-pursuing
04 Aug 2018
// Prabha R ECONOMIC TIMES
https://www.pharmacompass.com/pdf/news/health-ministry-likely-to-ban-over-300-combo-drugs-1533375391.pdf
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?